ICOSLG and rheumatoid arthritis: We found that RA antigen-presenting cells have raised CD56 in DC2 and DC3 and intermediate monocytes and increased the surface expression of the co-stimulatory molecules CD86 and CD275 (ICOS-L) in DC2.